In the absence of right ventricular hypertrophy or bundle-branch block, a prominent R wave in V1 or V2 is considered to reflect a lateral myocardial infarction. We investigated the differences in infarct location and size between patients with prominent R wave in V 1 and those with prominent R wave in V2.
Introduction and Objectives:
In the absence of right ventricular hypertrophy or bundle-branch block, a prominent R wave in V1 or V2 is considered to reflect a lateral myocardial infarction. We investigated the differences in infarct location and size between patients with prominent R wave in V 1 and those with prominent R wave in V2.
Methods:
We studied 50 patients with a previous first infarction involving left ventricular inferior and/or lateral wall at myocardial scintigraphy Results: A prominent R wave in V1 was present in 8 patients (16%), in V2 in 23 (46%). At myocardial scintigraphy, the infarction involved the inferior wall in 11 patients (22%), the lateral wall in 6 (12%), and both walls in 33 patients (66%). The sensitivity of a prominent R wave in V1 in detecting a lateral infarction was low (17.9%), while the specificity was high (90.9%). The sensitivity and specificity of a prominent R wave in V2 were 46.2% and 54.5%, respectively. In patients with a prominent R wave in V1, infarct size and lateral extent were greater than in patients without this pattern (P<.005 and <.0.01 respectively). In patients with a prominent R wave in V2, infarct size, lateral extent were not different from patients without this pattern.
Conclusions:
Only a prominent R wave in V1 is a specific sign of large lateral infarction. Of these procédures 40 were realized in the setting of acute coronary syndroms (15 ST elevation myocardial Infarction -STEMI -and 25 non STEMI). 42 BVS have been implanted through a radial approach on the culprit lesion under angiographic control alone. Left anterior descending artery was involved in 19, the right coronary artery in 14 and the left circumflex in 7 patients.18 patients had multivesseldesease and underwent a second staged procedure before discharge with BVS or metallic drug eluting stents implantation
In hospital stay was event free for all 40 patients. All were discharged under conventionnal dual antiplatellet therapy.
Out hospital follow up (11.2 months -2-22): no clinical event occured. One patient experienced 70% restenosis proximal to the stent and underwent new stenting with metallic drug eluting stent (TLR: 2.5%).
Conclusions: at that time our preliminary data confirm the safety at mid term of the BVS device in acute coronary syndroms.
Phosphoinositide 3-kinase gamma: a potential clinical target in the prevention of vascular damages inuced by arterial injury
Adrien Lupieri (1), Natalia Smirnova (1), Gervaise Loirand (2), JeanFrancois Arnal (1), Nathalie Vailland (2), Nicole Malet (1), Matthias Wymann (3), Emilio Hirsch (4), Alain-Pierre Gadeau (5), Laurent Martinez (1), Abdelhadi Saoudi (6), Stephanie Gayral (1) Context: Angioplasty with stent placement, used to treat symptomatic atherosclerosis plaques, is frequently complicated by restenosis. This pathology is characteried by fibroproliferative and immuno-inflammatory mechanisms of the arterial wall, called intimal hyperplasia (IH).
Aims:
Our previous results demonstrated that phosphoinositide 3-kinase γ (PI3Kγ ) was a key mediator of inflammatory processes of the arterial wall leading to atherosclerosis. We now proposed this enzyme as a potential clinical target to prevent vascular damages occuring after arterial lesion leading to IH. As cellular and molecular aspects of IH are still incompletely described, we intended to offer a better understanding ofimmune responses involved in this pathology.
Results: Using a mouse model of arterial mechanical injury, we showed that PI3Kγ -deficient mice and mice expressing a catalytically-inactive PI3Kγ (PI3Kγ KD) showed reduced arterial occlusion and accumulation of monocytes and T cells around site of vascular lesion. The transfer of PI3Kγ KD CD4 + T cells into Rag2-deficient mice greatly reduced vascular occlusion compared to WT cells, clearly demonstrating the involvement of PI3Kγ in CD4 + T cells during IH formation. In addition, we found that IH is associated with increased levels of Th1 and Th17 cytokines. A specific decrease in the Th1 response was observed in the absence of PI3Kγ activity, leading to decreased chemokine production by smooth muscle cells. Finally, we show that a short period of treatment with a PI3Kγ inhibitor decreased IH development in arterial mechanical injury in mice but also in a rat carotid artery balloon injury model demonstrating the therapeutic potential of this inhibitor. 
Conclusion

